Summary
: 
Introduction
The neuroleptics which have antidopaminergic effects also enhanced brain dopamine (DA) turnover (Carlsson, 1963) . Following administration of neuroleptics, the levels of DA metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were increased in several brain regions (Westerick, 1978) and a reduction in striatal DA fluorescence intensity was found in rats pretreated with alpha-methyl-paratyrosine (Yoshida et al. 1981) . The enhancement of DA turnover by neuroleptics seemed to be caused by positive feedback due to a DA receptor blocking action, however it is unknown whether the enhancement of DA turnover is due to feedback or a direct blockade of DA autoreceptors at sites on the DA nerve endings. Attempts were made to use a superf usion apparatus to clarify the mechanism of the enhancement of DA efflux by neuroleptics.
In the present study, longitudinal changes of DA efflux caused by haloperidol (HPD) superf usion and drug potencies of HPD, chlorpromazine (CPZ) and sulpiride (SUL) in enhancing DA efflux were investigated.
Materials and Methods
Male Wistar rats (180-250g) maintained in a light-, humidity-and temperaturecontrolled environment were used for all experiments.
The rats were sacrificed by decapitation and the brain was immediately removed.
Striatal slices, 0.5 mm thick were made with a Micro Slicer (Dosaka, E. M. Co.) in an ice cold Krebs solution at A 7190 to A 9650 according to the atlas of Konig and Klippel (1963) . Striatal portions of the slices were punched out with a stainless tube (3 mm i. d.).
Four slices were placed in a chamber made of teflon sylinge and superf used with an O2 saturated Krebs solution at a flow rate of 0.3 YAMADA, ET AL. Discussion Carlsson et al. (1963) reported that neuroleptics significantly increased DA synthesis and DA turnover in the nigrostriatal DA neurons. Gamma -butyrolactone treatment (Kehr et al. 1972) or an acute lesion of the nigro-striatal pathway (Carlsson et al. 1975) failed to reduce the stimulation of DA turnover in the striatum by the neuroleptics in vivo, suggesting that Anden et al. (1984) reported that the ED50's for presynaptic DA receptor blockade were 1 : 50 : 500 (HPD : CPZ : SUL) and those for postsynaptic DA receptor blockade were 1:5:37.5, For our investigation, the drug concentrations causing three fold increases in DA efflux above the basal efflux were 1 : 6.7: 167 (HPD : CPZ : SUL). 
